参考文献
［1］Leon MB，Piazza N，Nikolsky E，et al.Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials：a consensus report from the Valve Academic Research Consortium［J］.Eur Heart J，2011，32（2）：205-217.
［2］Kappetein AP，Head SJ，Généreux P，et al.Valve Academic Research Consortium-2.Updated standardized endpoint definitions for transcatheter aortic valve implantation：the Valve Academic Research Consortium-2 consensus document［J］.J Thorac Cardiovasc Surg，2013，145（1）：6-23.
［3］Godin M，Eltchaninoff H，Furuta A，et al.Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis［J］.Am J Cardiol，2010，106（5）：707-712.
［4］Bleiziffer S，Ruge H，Hörer J，et al.Predictors for new-onset complete heart block after transcatheter aortic valve implantation［J］.JACC Cardiovasc Interv，2010，3（5）：524-530.
［5］Erkapic D，De Rosa S，Kelava A，et al. Risk for permanent pacemaker after transcatheter aortic valve implantation：a comprehensive analysis of the literature［J］.J Cardiovasc Electrophysiol，2012，23（4）：391-397.
［6］Jørgensen TH，De Backer O，Gerds TA，et al. Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement［J］.JACC Cardiovasc Interv，2019，12（1）：52-61.
［7］Kodali SK，Williams MR，Smith CR，et al.Two-year outcomes after transcatheter or surgical aortic-valve replacement［J］.N Engl J Med，2012，366（18）：1686-1695.
［8］Gafoor S，Franke J，Piayda K，et al.Paravalvular leak closure after transcatheter aortic valve replacement with a self-expanding prosthesis［J］.Catheter Cardiovasc Interv，2014，84（1）：147-154.
［9］John D，Buellesfeld L，Yuecel S，et al.Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis［J］.JACC Cardiovasc Interv，2010，3（2）：233-243.
［10］Détaint D，Lepage L，Himbert D，et al.Determinants of significant paravalvular regurgitation after transcatheter aortic valve：implantation impact of device and annulus discongruence［J］.JACC Cardiovasc Interv，2009，2（9）：821-827.
［11］Eggebrecht H，Schmermund A，Voigtländer T，et al.Risk of stroke after transcatheter aortic valve implantation（TAVR）：a metaanalysis of 10，037 published patients［J］.EuroIntervention，2012，8（1）：129-138.
［12］Ghanem A，Müller A，Nähle CP，et al.Risk and fate of cerebral embolism after transfemoral aortic valve implantation：a prospective pilot study with diffusion-weighted magnetic resonance imaging［J］.J Am Coll Cardiol，2010，55：1427-1432.
［13］Leon MB，Smith CR，Mack M，et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery［J］.N Engl J Med，2010，363：1597-1607.(https://www.daowen.com)
［14］Lansky AJ，Schofer J，Tchetche D，et al.A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation：results from the DEFLECT Ⅲ trial［J］.Eur Heart J，2015，36（31）：2070-2078.
［15］Van Mieghem NM，Nuis RJ，et al.Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System：the Rotterdam experience［J］.EuroIntervention，2010，5（6）：673-679.
［16］Sharp AS，Michev I，Maisano F，et al. A new technique for vascular access management in transcatheter aortic valve implantation［J］.Catheter Cardiovasc Interv，2010，75（5）：784-793.
［17］Van Mieghem NM，Tchetche D，et al.Incidence，predictors，and implications of access site complications with transfemoral transcatheter aortic valve implantation［J］.Am J Cardiol，2012，110（9）：1361-1367.
［18］Rodés-Cabau J，Gutiérrez M，Bagur R，et al.Incidence，predictive factors，and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation［J］.J Am Coll Cardiol，2011，57（20）：1988-1999.
［19］Ribeiro HB，Webb JG，Makkar RR，et al.Predictive factors，management，and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation：insights from a large multicenter registry［J］.J Am Coll Cardiol，2013，62（17）：1552-1562.
［20］Jilaihawi H，Asch FM，Manasse E，et al.Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis［J］.JACC Cardiovasc Imaging，2017，10（4）：461-470.
［21］Spartera M，Ancona F，Barletta M，et al.Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis［J］.Echocardiography，2017.
［22］Grube E，Schuler G，Buellesfeld L，et al.Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis：device success and 30-day clinical outcome［J］.J Am C oll C ardiol，2007，50：69-76.
［23］Elhmidi Y，Bleiziffer S，Piazza N，et al.Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation［J］.Am Heart J，2011，161（4）：735-739.
［24］Moreno R，Calvo L，Salinas P，et al.Causes of peri-operative mortality after transcatheter aortic valve implantation：a pooled analysis of 12 studies and 1223 patients［J］.J Invasive Cardiol，2011，23（5）：180-184.
［25］Wendt D，Eggebrecht H，Kahlert P，et al.Experience and learning curve with transapical aortic valve implantation［J］.Herz，2009，34（5）：388-397.